TY - JOUR
T1 - Retrospective application of risk scores to ruptured intracranial aneurysms: would they have predicted the risk of bleeding?
AU - Sturiale, Carmelo Lucio
AU - Stumpo, Vittorio
AU - Ricciardi, Luca
AU - Trevisi, Gianluca
AU - Valente, Iacopo
AU - D'Arrigo, Sonia
AU - Latour, Kristy
AU - Barbone, Paolo
AU - Albanese, Alessio
PY - 2021
Y1 - 2021
N2 - As the incidental diagnosis of unruptured intracranial aneurysms has been increasing, several scores were developed to predict risk of rupture and growth to guide the management choice. We retrospectively applied these scores to a multicenter series of patients with subarachnoid hemorrhage to test whether they would have predicted the risk of bleeding in the event of aneurysm discovery previous to its rupture. Demographical, clinical, and radiological information of 245 adults were retrieved from two neurovascular centers' database. Data were pooled and PHASES, UCAS, and ELAPSS scores were retrospectively calculated for the whole population and their performances in identifying aneurysms at risk of rupture were compared. Mean PHASES, UCAS, and ELAPSS scores were 5.12 +/- 3.08, 5.09 +/- 2.62, and 15.88 +/- 8.07, respectively. Around half (46%) of patients would have been assigned to the low- or very low-risk class (5-year rupture risk < 1%) in PHASES. Around 28% of patients would have been in a low-risk class, with a probability of 3-year rupture risk < 1% according to UCAS. Finally, ELAPSS score application showed a wider distribution among the risk classes, but a significant proportion of patients (45.5%) lie in the low- or intermediate-risk class for aneurysm growth. A high percentage of patients with ruptured aneurysms in this multicenter cohort would have been assigned to the lower risk categories for aneurysm growth and rupture with all the tested scores if they had been discovered before the rupture. Based on these observations, physicians should be careful about drawing therapeutic conclusions solely based on application of these scores.
AB - As the incidental diagnosis of unruptured intracranial aneurysms has been increasing, several scores were developed to predict risk of rupture and growth to guide the management choice. We retrospectively applied these scores to a multicenter series of patients with subarachnoid hemorrhage to test whether they would have predicted the risk of bleeding in the event of aneurysm discovery previous to its rupture. Demographical, clinical, and radiological information of 245 adults were retrieved from two neurovascular centers' database. Data were pooled and PHASES, UCAS, and ELAPSS scores were retrospectively calculated for the whole population and their performances in identifying aneurysms at risk of rupture were compared. Mean PHASES, UCAS, and ELAPSS scores were 5.12 +/- 3.08, 5.09 +/- 2.62, and 15.88 +/- 8.07, respectively. Around half (46%) of patients would have been assigned to the low- or very low-risk class (5-year rupture risk < 1%) in PHASES. Around 28% of patients would have been in a low-risk class, with a probability of 3-year rupture risk < 1% according to UCAS. Finally, ELAPSS score application showed a wider distribution among the risk classes, but a significant proportion of patients (45.5%) lie in the low- or intermediate-risk class for aneurysm growth. A high percentage of patients with ruptured aneurysms in this multicenter cohort would have been assigned to the lower risk categories for aneurysm growth and rupture with all the tested scores if they had been discovered before the rupture. Based on these observations, physicians should be careful about drawing therapeutic conclusions solely based on application of these scores.
KW - ELAPSS score
KW - Intracranial aneurysm
KW - PHASES score
KW - Subarachnoid hemorrhage
KW - UCAS study
KW - ELAPSS score
KW - Intracranial aneurysm
KW - PHASES score
KW - Subarachnoid hemorrhage
KW - UCAS study
UR - http://hdl.handle.net/10807/304216
U2 - 10.1007/s10143-020-01352-w
DO - 10.1007/s10143-020-01352-w
M3 - Article
SN - 0344-5607
VL - 44
SP - 1655
EP - 1663
JO - Neurosurgical Review
JF - Neurosurgical Review
ER -